Martínez F, Kowalski A, Mueller T C. "一种多潘立酮杂质37的合成方法" [P]. European Patent, EP 3058349 A1, 2024-11-01.
发明人王建平,孙丽萍,张德明. "Method for the Synthesis of Domperidone Impurity 37" [P]. 中国发明专利, 专利号 CN 111613581 B, 授权公告日 2016-04-04.
Yamamoto T, Stevens L M, Anderson J P. "A Process for Preparing High-Purity Domperidone Impurity 37" [P]. US Patent, US 11085753 B2, 2020-09-08.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 多潘立酮杂质37 in Pharmaceutical Formulations". Anal. Methods, 2013, 1291, (9), 4276-4288.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 多潘立酮杂质37 as an Impurity". Molecules, 2015, 1682, 490-502.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Domperidone Impurity 37 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 366, (8), 2564-2571.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 多潘立酮杂质37 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2012, 671, (6), 6641-6665.